71 research outputs found
Preliminary results on the effects of orthopedic implant stiffness fixed to the cut end of the femur on the stress at the stump-prosthetic interface
A lot of trans-femoral amputation patients experience skin breakdown due to the pressures and shear stresses in the stump-prosthesis interface. In this study, a finite element model was employed to investigate the stresses at the stump interface in the case of an orthopedic implant fixed to the cut end of the femur. By changing the stiffness of this implant, we aim to see how the stiffness of this implant affects the stresses in the interface between the amputated limb and the prosthesis. To find out the effects of implant stiffness, five values for the elastic modulus, ranging from 0.1 to 0.5 Mpa, with an interval of 0.1 Mpa were employed in the implant structure of the FE model.
Obtained results show that the implant played important role in reducing the stresses at the stump-prosthesis interface where the contact pressure did not exceed 53 Kpa and 17.3 Kpa for shear stress in the stiffer case of an implant, while the contact pressure in the case of femur without implant exceeded 79Kpa and 42 Kpa for shear stress. We also noted that the intensity of the contact pressure and the shear stress is proportional to the stiffness of the implant, as the greater the implant stiffness, the higher the peak of these stresses
Hydrogen production on iron–magnesium oxide in the high-temperature water-gas shift reaction
Time delay in the Einstein-Straus solution
The time delay of strong lensing is computed in the framework of the
Einstein-Straus solution. The theory is compared to the observational bound on
the time delay of the lens SDSS J1004+4112.Comment: 20 pages, 4 tables, 1 figur
Quasi-degenerate neutrinos and tri-bi-maximal mixing
Assuming high-energy tri-bi-maximal mixing we study the radiative running of
leptonic mixing angles and obtain limits on the high-energy scale from
requiring consistency with the observed mixing. We construct a model in which a
non-Abelian discrete family symmetry leads both to a quasi-degenerate neutrino
mass spectrum and to near tri-bi-maximal mixing.Comment: 7 pages, to appear in the proceedings of DISCRETE'0
The Interplay Between GUT and Flavour Symmetries in a Pati-Salam x S4 Model
Both Grand Unified symmetries and discrete flavour symmetries are appealing
ways to describe apparent structures in the gauge and flavour sectors of the
Standard Model. Both symmetries put constraints on the high energy behaviour of
the theory. This can give rise to unexpected interplay when building models
that possess both symmetries. We investigate on the possibility to combine a
Pati-Salam model with the discrete flavour symmetry that gives rise to
quark-lepton complementarity. Under appropriate assumptions at the GUT scale,
the model reproduces fermion masses and mixings both in the quark and in the
lepton sectors. We show that in particular the Higgs sector and the running
Yukawa couplings are strongly affected by the combined constraints of the Grand
Unified and family symmetries. This in turn reduces the phenomenologically
viable parameter space, with high energy mass scales confined to a small region
and some parameters in the neutrino sector slightly unnatural. In the allowed
regions, we can reproduce the quark masses and the CKM matrix. In the lepton
sector, we reproduce the charged lepton masses, including bottom-tau
unification and the Georgi-Jarlskog relation as well as the two known angles of
the PMNS matrix. The neutrino mass spectrum can present a normal or an inverse
hierarchy, and only allowing the neutrino parameters to spread into a range of
values between and , with .
Finally, our model suggests that the reactor mixing angle is close to its
current experimental bound.Comment: 62 pages, 4 figures; references added, version accepted for
publication in JHE
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in intermediate- and advanced-stage children and adolescents with classic Hodgkin lymphoma: a titration study with an embedded non-inferiority randomised controlled trial
BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after treatment with vincristine, etoposide, prednisone, and doxorubicin (OEPA) followed by cyclophosphamide, vincristine, prednisone, and procarbazine (COPP) and radiotherapy, but long-term treatment effects affect survival and quality of life. We aimed to investigate whether radiotherapy can be omitted in patients with morphological and metabolic adequate response to OEPA and whether modified consolidation chemotherapy reduces gonadotoxicity. METHODS: Our study was designed as a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial, and was carried out at 186 hospital sites across 16 European countries. Children and adolescents with newly diagnosed intermediate-stage (treatment group 2) and advanced-stage (treatment group 3) classical Hodgkin lymphoma who were younger than 18 years and stratified according to risk using Ann Arbor disease stages IIAE, IIB, IIBE, IIIA, IIIAE, IIIB, IIIBE, and all stages IV (A, B, AE, and BE) were included in the study. Patients with early disease (treatment group 1) were excluded from this analysis. All patients were treated with two cycles of OEPA (1·5 mg/m(2) vincristine taken intravenously capped at 2 mg, on days 1, 8, and 15; 125 mg/m(2) etoposide taken intravenously on days 1–5; 60 mg/m(2) prednisone taken orally on days 1–15; and 40 mg/m(2) doxorubicin taken intravenously on days 1 and 15). Patients were randomly assigned to two (treatment group 2) or four (treatment group 3) cycles of COPP (500 mg/m(2) cyclophosphamide taken intravenously on days 1 and 8; 1·5 mg/m(2) vincristine taken intravenously capped at 2 mg, on days 1 and 8; 40 mg/m(2) prednisone taken orally on days 1 to 15; and 100 mg/m(2) procarbazine taken orally on days 1 to 15) or COPDAC, which was identical to COPP except that 250 mg/m(2) dacarbazine administered intravenously on days 1 to 3 replaced procarbazine. The method of randomisation (1:1) was minimisation with stochastic component and was centrally stratified by treatment group, country, trial sites, and sex. The primary endpoint was event-free survival, defined as time from treatment start until the first of the following events: death from any cause, progression or relapse of classical Hodgkin lymphoma, or occurrence of secondary malignancy. The primary objectives were maintaining 90% event-free survival at 5 years in patients with adequate response to OEPA treated without radiotherapy and to exclude a decrease of 8% in event-free survival at 5 years in the embedded COPDAC versus COPP randomisation to show non-inferiority of COPDAC. Efficacy analyses are reported per protocol and safety in the intention-to-treat population. The trial is registered with ClinicalTrials.gov (trial number NCT00433459) and EUDRACT (trial number 2006-000995-33), and is closed to recruitment. FINDINGS: Between Jan 31, 2007, and Jan 30, 2013, 2102 patients were recruited. 737 (35%) of the 2102 recruited patients were in treatment group 1 (early-stage disease) and were not included in our analysis. 1365 (65%) of the 2102 patients were in treatment group 2 (intermediate-stage disease; n=455) and treatment group 3 (advanced-stage disease; n=910). Of these 1365, 1287 (94%) patients (435 [34%] of 1287 in treatment group 2 and 852 [66%] of 1287 in treatment group 3) were included in the titration trial per-protocol analysis. 937 (69%) of 1365 patients were randomly assigned to COPP (n=471) or COPDAC (n=466) in the embedded trial. Median follow-up was 66·5 months (IQR 62·7–71·7). Of 1287 patients in the per-protocol group, 514 (40%) had an adequate response to treatment and were not treated with radiotherapy (215 [49%] of 435 in treatment group 2 and 299 [35%] of 852 in treatment group 3). 773 (60%) of 1287 patients with inadequate response were scheduled for radiotherapy (220 [51%] of 435 in the treatment group 2 and 553 [65%] of 852 in treatment group 3. In patients who responded adequately, event-free survival rates at 5 years were 90·1% (95% CI 87·5–92·7). event-free survival rates at 5 years in 892 patients who were randomly assigned to treatment and analysed per protocol were 89·9% (95% CI 87·1–92·8) for COPP (n=444) versus 86·1% (82·9–89·4) for COPDAC (n=448). The COPDAC minus COPP difference in event-free survival at 5 years was −3·7% (−8·0 to 0·6). The most common grade 3–4 adverse events (intention-to-treat population) were decreased haemoglobin (205 [15%] of 1365 patients during OEPA vs 37 [7%] of 528 treated with COPP vs 20 [2%] of 819 treated with COPDAC), decreased white blood cells (815 [60%] vs 231 [44%] vs 84 [10%]), and decreased neutrophils (1160 [85%] vs 223 [42%] vs 174 [21%]). One patient in treatment group 2 died of sepsis after the first cycle of OEPA; no other treatment-related deaths occurred. INTERPRETATION: Our results show that radiotherapy can be omitted in patients who adequately respond to treatment, when consolidated with COPP or COPDAC. COPDAC might be less effective, but is substantially less gonadotoxic than COPP. A high proportion of patients could therefore be spared radiotherapy, eventually reducing the late effects of treatment. With more refined criteria for response assessment, the number of patients who receive radiotherapy will be further decreased. FUNDING: Deutsche Krebshilfe, Elternverein für Krebs-und leukämiekranke Kinder Gießen, Kinderkrebsstiftung Mainz, Tour der Hoffnung, Menschen für Kinder, Programme Hospitalier de Recherche Clinique, and Cancer Research UK
Renormalisation group corrections to neutrino mixing sum rules
Neutrino mixing sum rules are common to a large class of models based on the
(discrete) symmetry approach to lepton flavour. In this approach the neutrino
mixing matrix is assumed to have an underlying approximate symmetry form
\tildeU_\nu, which is dictated by, or associated with, the employed
(discrete) symmetry. In such a setup the cosine of the Dirac CP-violating phase
can be related to the three neutrino mixing angles in terms of a sum
rule which depends on the symmetry form of \tildeU_\nu. We consider five
extensively discussed possible symmetry forms of \tildeU_\nu: i)
bimaximal (BM) and ii) tri-bimaximal (TBM) forms, the forms corresponding to
iii) golden ratio type A (GRA) mixing, iv) golden ratio type B (GRB) mixing,
and v) hexagonal (HG) mixing. For each of these forms we investigate the
renormalisation group corrections to the sum rule predictions for in
the cases of neutrino Majorana mass term generated by the Weinberg (dimension
5) operator added to i) the Standard Model, and ii) the minimal SUSY extension
of the Standard Model
Influence du support sur la structure cristalline et l'activité catalytique des systèmes à base de fer en réaction CO+H2O
nationa
- …